Announcement of Intent To Solicit and Issue One OPDIV-Initiated Supplement to Lutheran Immigration and Refugee Service, Inc. Under the Standing Announcement for Residential (Shelter) Services for Unaccompanied Children, HHS-2017-ACF-ORR-ZU-1132, 42659 [2018-18230]
Download as PDF
Federal Register / Vol. 83, No. 164 / Thursday, August 23, 2018 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
[CFDA Number: 93.676]
Announcement of Intent To Solicit and
Issue One OPDIV-Initiated Supplement
to Lutheran Immigration and Refugee
Service, Inc. Under the Standing
Announcement for Residential
(Shelter) Services for Unaccompanied
Children, HHS–2017–ACF–ORR–ZU–
1132
Unaccompanied Alien
Children (UAC) Program, Office of
Refugee Resettlement (ORR),
Administration for Children and
Families (ACF), U.S. Department of
Health and Human Services (HHS).
ACTION: Notice of solicitation and intent
to issue of one OPDIV-Initiated
Supplement to Lutheran Immigration
and Refugee Service, Inc., Baltimore,
MD under the UAC Program.
AGENCY:
ACF, ORR announces the
solicitation and intent to issue one
OPDIV-Initiated Supplement to
Lutheran Immigration and Refugee
Service, Inc., Baltimore, MD in an
amount not to exceed $1,000,000.
ORR has been identifying additional
capacity for fingerprinting services for
an expected increase in the number of
sponsors (parents, guardians, or family
friends to whom the UAC will be
released) who will need to be
fingerprinted. Planning for increased
fingerprinting capacity is a prudent step
to ensure that ORR is able to meet its
responsibility, by law, to ensure that the
sponsor has not engaged in any activity
that would indicate a potential risk to
the UAC.
DATES: Supplemental award funds will
support activities for up to eight months
after award.
FOR FURTHER INFORMATION CONTACT:
Jallyn Sualog, Director, Division of
Unaccompanied Children Operations,
Office of Refugee Resettlement, 330 C
Street SW, Washington, DC 20201.
Telephone: 202–401–4997; email:
jallyn.sualog@acf.hhs.gov.
SUPPLEMENTARY INFORMATION: ORR is
continuously monitoring its capacity to
provide fingerprinting services to the
sponsors of UAC referred to HHS, as
well as the information received from
interagency partners, to inform any
future decisions or actions.
daltland on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:43 Aug 22, 2018
Jkt 244001
ORR has specific requirements for the
provision of services. Award recipients
must have the infrastructure, licensing,
experience, and appropriate level of
trained staff to meet those requirements.
The expansion of the existing program
and its services through this
supplemental award is a key strategy for
ORR to be prepared to meet its
responsibility to provide fingerprinting
services to the sponsors of UAC referred
to its care by DHS.
ORR plans to solicit an application
from Lutheran Immigration and Refugee
Service, Inc., Baltimore, MD to meet the
fingerprinting needs. If the application
received a favorable objective review,
ORR intends to issue a supplement in
the amount up to $1,000,000.
Statutory Authority: This program is
authorized by—
(A) Section 462 of the Homeland
Security Act of 2002, which in March
2003, transferred responsibility for the
care and custody of Unaccompanied
Alien Children from the Commissioner
of the former Immigration and
Naturalization Service (INS) to the
Director of ORR of the Department of
Health and Human Services (HHS).
(B) The Flores Settlement Agreement,
Case No. CV85–4544RJK (C.D. Cal.
1996), as well as the William
Wilberforce Trafficking Victims
Protection Reauthorization Act of 2008
(Pub. L. 110–457), which authorizes
post release services under certain
conditions to eligible children. All
programs must comply with the Flores
Settlement Agreement, Case No. CV85–
4544–RJK (C.D. Cal. 1996), pertinent
regulations and ORR policies and
procedures.
ACTION:
42659
Notice.
The Food and Drug
Administration (FDA) is requesting
nominations for voting members to
serve on the Device Good
Manufacturing Practice Advisory
Committee and device panels of the
Medical Devices Advisory Committee in
the Center for Devices and Radiological
Health. This annual notice is also in
accordance with the 21st Century Cures
Act, which requires the Secretary to
provide an annual opportunity for
patients, representatives of patients, and
sponsors of medical devices that may be
specifically the subject of a review by a
classification panel to provide
recommendations for individuals with
appropriate expertise to fill voting
member positions on classification
panels.
FDA seeks to include the views of
women and men, members of all racial
and ethnic groups, and individuals with
and without disabilities on its advisory
committees and, therefore, encourages
nominations of appropriately qualified
candidates from these groups.
SUMMARY:
Nominations received on or
before October 22, 2018 will be given
first consideration for membership on
the Device Good Manufacturing Practice
Advisory Committee and Panels of the
Medical Devices Advisory Committee.
Nominations received after October 22,
2018 will be considered for nomination
to the committee as later vacancies
occur.
DATES:
Food and Drug Administration
All nominations for
membership should be submitted
electronically by logging into the FDA
Advisory Nomination Portal: https://
www.accessdata.fda.gov/scripts/
FACTRSPortal/FACTRS/index.cfm or by
mail to Advisory Committee Oversight
and Management Staff, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 32, Rm. 5103, Silver Spring,
MD 20993–0002.
[Docket No. FDA–2018–N–3079]
FOR FURTHER INFORMATION CONTACT:
Elizabeth Leo,
Grants Policy Specialist, Division of Grants
Policy, Office of Administration.
[FR Doc. 2018–18230 Filed 8–22–18; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Request for Nominations for Voting
Members on Public Advisory Panels or
Committees; Device Good
Manufacturing Practice Advisory
Committee and the Medical Devices
Advisory Committee
AGENCY:
ADDRESSES:
Regarding all nomination questions for
membership, contact the following
persons listed in table 1:
Food and Drug Administration,
HHS.
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
E:\FR\FM\23AUN1.SGM
23AUN1
Agencies
[Federal Register Volume 83, Number 164 (Thursday, August 23, 2018)]
[Notices]
[Page 42659]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-18230]
[[Page 42659]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
[CFDA Number: 93.676]
Announcement of Intent To Solicit and Issue One OPDIV-Initiated
Supplement to Lutheran Immigration and Refugee Service, Inc. Under the
Standing Announcement for Residential (Shelter) Services for
Unaccompanied Children, HHS-2017-ACF-ORR-ZU-1132
AGENCY: Unaccompanied Alien Children (UAC) Program, Office of Refugee
Resettlement (ORR), Administration for Children and Families (ACF),
U.S. Department of Health and Human Services (HHS).
ACTION: Notice of solicitation and intent to issue of one OPDIV-
Initiated Supplement to Lutheran Immigration and Refugee Service, Inc.,
Baltimore, MD under the UAC Program.
-----------------------------------------------------------------------
SUMMARY: ACF, ORR announces the solicitation and intent to issue one
OPDIV-Initiated Supplement to Lutheran Immigration and Refugee Service,
Inc., Baltimore, MD in an amount not to exceed $1,000,000.
ORR has been identifying additional capacity for fingerprinting
services for an expected increase in the number of sponsors (parents,
guardians, or family friends to whom the UAC will be released) who will
need to be fingerprinted. Planning for increased fingerprinting
capacity is a prudent step to ensure that ORR is able to meet its
responsibility, by law, to ensure that the sponsor has not engaged in
any activity that would indicate a potential risk to the UAC.
DATES: Supplemental award funds will support activities for up to eight
months after award.
FOR FURTHER INFORMATION CONTACT: Jallyn Sualog, Director, Division of
Unaccompanied Children Operations, Office of Refugee Resettlement, 330
C Street SW, Washington, DC 20201. Telephone: 202-401-4997; email:
[email protected].
SUPPLEMENTARY INFORMATION: ORR is continuously monitoring its capacity
to provide fingerprinting services to the sponsors of UAC referred to
HHS, as well as the information received from interagency partners, to
inform any future decisions or actions.
ORR has specific requirements for the provision of services. Award
recipients must have the infrastructure, licensing, experience, and
appropriate level of trained staff to meet those requirements. The
expansion of the existing program and its services through this
supplemental award is a key strategy for ORR to be prepared to meet its
responsibility to provide fingerprinting services to the sponsors of
UAC referred to its care by DHS.
ORR plans to solicit an application from Lutheran Immigration and
Refugee Service, Inc., Baltimore, MD to meet the fingerprinting needs.
If the application received a favorable objective review, ORR intends
to issue a supplement in the amount up to $1,000,000.
Statutory Authority: This program is authorized by--
(A) Section 462 of the Homeland Security Act of 2002, which in
March 2003, transferred responsibility for the care and custody of
Unaccompanied Alien Children from the Commissioner of the former
Immigration and Naturalization Service (INS) to the Director of ORR of
the Department of Health and Human Services (HHS).
(B) The Flores Settlement Agreement, Case No. CV85-4544RJK (C.D.
Cal. 1996), as well as the William Wilberforce Trafficking Victims
Protection Reauthorization Act of 2008 (Pub. L. 110-457), which
authorizes post release services under certain conditions to eligible
children. All programs must comply with the Flores Settlement
Agreement, Case No. CV85-4544-RJK (C.D. Cal. 1996), pertinent
regulations and ORR policies and procedures.
Elizabeth Leo,
Grants Policy Specialist, Division of Grants Policy, Office of
Administration.
[FR Doc. 2018-18230 Filed 8-22-18; 8:45 am]
BILLING CODE 4184-01-P